Ranolazin: mechanism of antianginal effects

---

Atıf İçin Kopyala

Ozdemir M.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.44, ss.8-12, 2016 (ESCI)

• Yayın Türü: Makale / Derleme
• Cilt numarası: 44
• Basım Tarihi: 2016
• Doi Numarası: 10.5543/tkda.2016.72626
• Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.8-12
• Gazi Üniversitesi Adresli: Evet

Özet

Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a "metabolic modulator", ranolazine is now considered to be a "late sodium current blocker". This review tries to summarize the mechanism of antianginal effects of ranolazine.